ChemicalBook > CAS DataBase List > Eptinezumab

Eptinezumab

Product Name
Eptinezumab
CAS No.
1644539-04-7
Chemical Name
Eptinezumab
Synonyms
Eptinezumab;Eptinezumab (anti-CGRP);Research Grade Eptinezumab(DHC22403)
CBNumber
CB83143795
Formula Weight
0
MOL File
Mol file
More
Less

Eptinezumab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

Eptinezumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Eptinezumab Suppliers

China 13 United States 1 Global 14
ShangHai Biochempartner Co.,Ltd
Tel
17754423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8014
Advantage
62
Nanjing Peptide Biotech Ltd.
Tel
025-025-58361106-805-805 13082558573
Fax
025-58361106-806
Email
liugang@njpeptide.com
Country
China
ProdList
9978
Advantage
55
Nanjing Meihao Pharmaceutical Technology Co., Ltd.
Tel
meitaochem@126.com
Email
meitaochem@126.com
Country
China
ProdList
19105
Advantage
58
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471 +1-2135480471
Email
sales@sarms4muscle.com
Country
China
ProdList
10522
Advantage
58
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1565
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ：422450190
Email
422450190@qq.com
Country
China
ProdList
10351
Advantage
58
Biolab Reagents
Tel
027-65279366 18162686757
Email
products@biolabreagent.com
Country
China
ProdList
9818
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
5731
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11975
Advantage
58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd
Tel
021-59167510 18117107507
Email
vip@med-life.cn
Country
China
ProdList
5012
Advantage
58

1644539-04-7, EptinezumabRelated Search:

Urelumab varlilumab Atezolizumab Obinutuzumab Sutimlimab Utomilumab Glofitamab Nesvacumab Odronextamab Rituximab

  • Eptinezumab
  • Research Grade Eptinezumab(DHC22403)
  • Eptinezumab (anti-CGRP)
  • 1644539-04-7